Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05724433 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization

Study acronym: VICTORY-HF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 7, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 9 months later Dec 31, 2025 → Sep 30, 2026
Primary endpoints added 2 → 4 primary endpoints
See other at-risk trials from Population Health Research Institute

Record History

  1. Primary completion pushed from Dec 31, 2025 to Sep 30, 2026 Primary endpoint(s) modified · Secondary endpoints: 4 to 3 · Study description expanded, about 25 words · 1 morev3 Show 4 more changesShow less
    • Primary endpoint(s) modified
    • Secondary endpoints: 4 to 3
    • Study description expanded, about 25 words
    • Site details revised at 1 of 9 sites

    See this version in full on ClinicalTrials.gov ↗

  2. Enrollment target: 50 to 891 Primary completion date: Jun 9, 2023 to Dec 31, 2025 · Start date: Dec 9, 2022 to Jan 23, 2023 · Primary endpoints: 1 to 2 · 6 morev2 Show 9 more changesShow less
    • Primary completion date: Jun 9, 2023 to Dec 31, 2025
    • Start date: Dec 9, 2022 to Jan 23, 2023
    • Primary endpoints: 1 to 2
    • Study sites: 3 to 9
    • Completion date: Nov 30, 2023 to Dec 31, 2026
    • Eligibility criteria expanded, about 122 words
    • Secondary endpoints: 7 to 4
    • Study description expanded, about 163 words
    • Study title shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.
Trial Details
NCT Number NCT05724433
Lead Sponsor Population Health Research Institute
Collaborators: Hamilton Health Sciences Corporation, McMaster University
Conditions Heart Failure
Enrollment 891 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov